Your browser doesn't support javascript.
loading
Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma.
Swoboda, Ryszard; Giebel, Sebastian; Knopinska-Posluszny, Wanda; Chmielowska, Ewa; Drozd-Sokolowska, Joanna; Paszkiewicz-Kozik, Ewa; Kulikowski, Waldemar; Taszner, Michal; Mendrek, Wlodzimierz; Najda, Jacek; Czerw, Tomasz; Olszewska-Szopa, Magdalena; Czyz, Anna; Giza, Agnieszka; Spychalowicz, Wojciech; Subocz, Edyta; Szwedyk, Pawel; Krzywon, Aleksandra; Wilk, Agata; Zaucha, Jan Maciej.
Afiliação
  • Swoboda R; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice branch, Gliwice, Poland.
  • Giebel S; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice branch, Gliwice, Poland.
  • Knopinska-Posluszny W; Department of Hematology and Bone Marrow Transplantation, Pomeranian Hospitals, Gdynia, Poland.
  • Chmielowska E; Oncologic Hospital, Tomaszów Mazowiecki, Poland.
  • Drozd-Sokolowska J; Department of Oncology, Oncology Centre, Bydgoszcz, Poland.
  • Paszkiewicz-Kozik E; Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.
  • Kulikowski W; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw branch, Warsaw, Poland.
  • Taszner M; Department of Hematology, Independent Public Health Care Ministry of the Interior of Warmia and Mazury Oncology Center, Olsztyn, Poland.
  • Mendrek W; Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland.
  • Najda J; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice branch, Gliwice, Poland.
  • Czerw T; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice branch, Gliwice, Poland.
  • Olszewska-Szopa M; Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice branch, Gliwice, Poland.
  • Czyz A; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Giza A; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Spychalowicz W; Department of Hematology, Jagiellonian University, Krakow, Poland.
  • Subocz E; InternalMedicine and Oncology Clinic, Silesian Medical University, Katowice, Poland.
  • Szwedyk P; Department of Hematology, Military Institute of Medicine, Warsaw, Poland.
  • Krzywon A; Department of Hematology, Ludwik Rydygier Hospital, Krakow, Poland.
  • Wilk A; Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
  • Zaucha JM; Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
Ann Hematol ; 100(7): 1919, 2021 Jul.
Article em En | MEDLINE | ID: mdl-33760951
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article